BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11738359)

  • 1. Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice.
    Leriche-Guérin K; Anderson LV; Wrogemann K; Roy B; Goulet M; Tremblay JP
    Neuromuscul Disord; 2002 Feb; 12(2):167-73. PubMed ID: 11738359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning of the mouse dysferlin gene and genomic characterization of the SJL-Dysf mutation.
    Vafiadaki E; Reis A; Keers S; Harrison R; Anderson LV; Raffelsberger T; Ivanova S; Hoger H; Bittner RE; Bushby K; Bashir R
    Neuroreport; 2001 Mar; 12(3):625-9. PubMed ID: 11234777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
    Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.
    Millay DP; Maillet M; Roche JA; Sargent MA; McNally EM; Bloch RJ; Molkentin JD
    Am J Pathol; 2009 Nov; 175(5):1817-23. PubMed ID: 19834057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy.
    Liu J; Aoki M; Illa I; Wu C; Fardeau M; Angelini C; Serrano C; Urtizberea JA; Hentati F; Hamida MB; Bohlega S; Culper EJ; Amato AA; Bossie K; Oeltjen J; Bejaoui K; McKenna-Yasek D; Hosler BA; Schurr E; Arahata K; de Jong PJ; Brown RH
    Nat Genet; 1998 Sep; 20(1):31-6. PubMed ID: 9731526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).
    Weiler T; Bashir R; Anderson LV; Davison K; Moss JA; Britton S; Nylen E; Keers S; Vafiadaki E; Greenberg CR; Bushby CR; Wrogemann K
    Hum Mol Genet; 1999 May; 8(5):871-7. PubMed ID: 10196377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of MHC class I expression accompanies but is not required for spontaneous myopathy in dysferlin-deficient SJL/J mice.
    Kostek CA; Dominov JA; Miller JB
    Am J Pathol; 2002 Mar; 160(3):833-9. PubMed ID: 11891182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.
    Tagawa K; Ogawa M; Kawabe K; Yamanaka G; Matsumura T; Goto K; Nonaka I; Nishino I; Hayashi YK
    J Neurol Sci; 2003 Jul; 211(1-2):23-8. PubMed ID: 12767493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL).
    Suzuki N; Aoki M; Hinuma Y; Takahashi T; Onodera Y; Ishigaki A; Kato M; Warita H; Tateyama M; Itoyama Y
    Neurosci Res; 2005 May; 52(1):47-60. PubMed ID: 15811552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of the dysferlin skeletal muscle promoter.
    Foxton RM; Laval SH; Bushby KM
    Eur J Hum Genet; 2004 Feb; 12(2):127-31. PubMed ID: 14560310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.
    Nagaraju K; Rawat R; Veszelovszky E; Thapliyal R; Kesari A; Sparks S; Raben N; Plotz P; Hoffman EP
    Am J Pathol; 2008 Mar; 172(3):774-85. PubMed ID: 18276788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies).
    Anderson LV; Harrison RM; Pogue R; Vafiadaki E; Pollitt C; Davison K; Moss JA; Keers S; Pyle A; Shaw PJ; Mahjneh I; Argov Z; Greenberg CR; Wrogemann K; Bertorini T; Goebel HH; Beckmann JS; Bashir R; Bushby KM
    Neuromuscul Disord; 2000 Dec; 10(8):553-9. PubMed ID: 11053681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
    Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
    Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.
    Wenzel K; Carl M; Perrot A; Zabojszcza J; Assadi M; Ebeling M; Geier C; Robinson PN; Kress W; Osterziel KJ; Spuler S
    Hum Mutat; 2006 Jun; 27(6):599-600. PubMed ID: 16705711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel, blood-based diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy.
    Ho M; Gallardo E; McKenna-Yasek D; De Luna N; Illa I; Brown RH
    Ann Neurol; 2002 Jan; 51(1):129-33. PubMed ID: 11782994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles.
    Vilquin JT; Guérette B; Puymirat J; Yaffe D; Tomé FM; Fardeau M; Fiszman M; Schwartz K; Tremblay JP
    Gene Ther; 1999 May; 6(5):792-800. PubMed ID: 10505103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy.
    Illarioshkin SN; Ivanova-Smolenskaya IA; Greenberg CR; Nylen E; Sukhorukov VS; Poleshchuk VV; Markova ED; Wrogemann K
    Neurology; 2000 Dec; 55(12):1931-3. PubMed ID: 11134403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myoblast transplantation in non-dystrophic dog.
    Ito H; Vilquin JT; Skuk D; Roy B; Goulet M; Lille S; Dugré FJ; Asselin I; Roy R; Fardeau M; Tremblay JP
    Neuromuscul Disord; 1998 Apr; 8(2):95-110. PubMed ID: 9608563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoferlin, a candidate gene and potential modifier of muscular dystrophy.
    Davis DB; Delmonte AJ; Ly CT; McNally EM
    Hum Mol Genet; 2000 Jan; 9(2):217-26. PubMed ID: 10607832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency.
    Prelle A; Sciacco M; Tancredi L; Fagiolari G; Comi GP; Ciscato P; Serafini M; Fortunato F; Zecca C; Gallanti A; Chiveri L; Bresolin N; Scarlato G; Moggio M
    Acta Neuropathol; 2003 Jun; 105(6):537-42. PubMed ID: 12734659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.